FDA 510(k)

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD

N.º K: K182138 · 2018-09-05

Fecha de decisión2018-09-05

Código de productoIYE

Comité asesorRA

DecisiónSubstantially Equivalent

Resumen del dispositivo

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD is the device name listed in this FDA 510(k) record. The listed applicant is Eleckta Limited. It received FDA 510(k) clearance on 2018-09-05 under 510(k) number K182138. The device is classified under product code IYE. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD?

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD is a medical device that received FDA 510(k) clearance on 2018-09-05. The listed applicant is Eleckta Limited. The 510(k) number is K182138.

When did Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD receive FDA 510(k) clearance?

Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD received FDA 510(k) clearance on 2018-09-05, under 510(k) number K182138.

Who is the listed applicant for Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD?

The FDA 510(k) record lists Eleckta Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD?

The FDA product code for Precise Treatment System; Synergy platform; Synergy; Infinity; VersaHD is IYE.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Dispositivos relacionados (Código: IYE)

K261865AerFrame™ Alignment Laser Box (LBV2)Stabilix, LLC K261718EZFluence (RADEZ V2)Radformation, Inc.K260733MRIA Radiation Therapy Information System (MRIA)Manteia Technologies Co., Ltd.K261856Halcyon, Ethos Radiotherapy System (5.0)Varian Medical Systems, Inc.K252937ThinkQA 3Dosisoft SA K253004LUNA 3DLap GmbH Laser Applikationen

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.